Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Andre G. Gouveia"'
Autor:
Gustavo A. Viani, Andre G. Gouveia, Ianara N.S.B. Silva, Gustavo S. Fernandes, Fabio Y. Moraes
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 116:413-420
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e27ce4d9c8cb99f71099684ce1a38576
https://doi.org/10.1016/j.ijrobp.2023.02.029
https://doi.org/10.1016/j.ijrobp.2023.02.029
Autor:
Gustavo A, Viani, Andre G, Gouveia, Fernando K, Matsuura, Alexandre A, Jacinto, Fabio Y, Moraes
Publikováno v:
Radiotherapy and Oncology. 173:41-48
Assess Once daily (OD) chemoradiation effectiveness for LS-SCLC compared with twice daily (BID) chemoradiation.Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guideline, eligible randomized clinical trials (R
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3dcfd08e3c13c63cf6a002b2d1bd907
https://doi.org/10.1016/j.radonc.2022.01.032
https://doi.org/10.1016/j.radonc.2022.01.032
Autor:
Gustavo A. Viani, Andre G. Gouveia, Juliana F. Pavoni, Alexander Vicent Louie, Jay Detsky, Daniel E. Spratt, Fabio Y. Moraes
Publikováno v:
Clinical Oncology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bff293f14cada7664b45e6b0f6a63fd1
https://doi.org/10.1016/j.clon.2023.04.004
https://doi.org/10.1016/j.clon.2023.04.004
Autor:
Gustavo A Viani, Andre G Gouveia, Vanessa F Bratti, Juliana F Pavoni, Richard Sullivan, Wilma M Hopman, Christopher M Booth, Ajay Aggarwal, Timothy P Hanna, Fabio Y Moraes
Publikováno v:
The Lancet Oncology. 23:531-539
Similarly to several other upper-middle-income countries, there is a major shortfall in radiotherapy services for the treatment of cancer in Brazil. In this study, we developed the linear accelerator (LINAC) shortage index to assess the LINAC shortag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0aceec918551102f05dbd8bc9ea05b9
https://doi.org/10.1016/s1470-2045(22)00123-1
https://doi.org/10.1016/s1470-2045(22)00123-1
Autor:
Juliana Fernandes Pavoni, Alexander V. Louie, Gustavo Arruda Viani, Andre G. Gouveia, Martin Korzeniowski, Fabio Y. Moraes, Ana Carolina Hamamura
Publikováno v:
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Universidade de São Paulo (USP)
instacron:USP
Objectives Stereotactic ablative radiotherapy (SABR) has been reported to be an effective treatment for oligometastatic disease from different primary cancer sites. Here we assess the effectiveness and safety of SABR for oligometastatic breast cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3544d49887dd046433e0c92dbeda8c0f
https://doi.org/10.1016/j.radonc.2021.09.031
https://doi.org/10.1016/j.radonc.2021.09.031
Publikováno v:
J Thorac Dis
BACKGROUND: For patients with locally advanced non-small cell lung cancer (NSCLC), the standard treatment is concurrent or sequential chemotherapy with radiotherapy. Most treatment schedules use radiotherapy with conventional fractionation; however,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9883342a0e945c6706616fb0a8202522
https://doi.org/10.21037/jtd-21-573
https://doi.org/10.21037/jtd-21-573
Autor:
Andre G. Gouveia, Nikitha Moideen, Horacio Patrocinio, Alejandro Berlin, Fabio Cury, Fabio Y. Moraes, Michael Yan, Vanessa F Bratti, Lucas C. Mendez
Publikováno v:
Nature Reviews. Urology
External beam radiotherapy is an effective curative treatment option for localized prostate cancer, the most common cancer in men worldwide. However, conventionally fractionated courses of curative external beam radiotherapy are usually 8–9 weeks l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e353dd823de9b820f5c2cfdda9a69de9
https://doi.org/10.1038/s41585-021-00498-6
https://doi.org/10.1038/s41585-021-00498-6
Publikováno v:
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 177
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc08574f71e555b48c32e03861b129c2
https://pubmed.ncbi.nlm.nih.gov/36265684
https://pubmed.ncbi.nlm.nih.gov/36265684
Publikováno v:
International journal of radiation oncology, biology, physics. 115(1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7eef3d0d5ba38e880f52c637061a1416
https://pubmed.ncbi.nlm.nih.gov/36526384
https://pubmed.ncbi.nlm.nih.gov/36526384
Autor:
Fabio Y. Moraes, Andre G. Gouveia, Renato P. Lima, Vanessa F. Bratti, Ana C. Hamamura, Gustavo A. Viani
Publikováno v:
Journal of cancer policy.
During the COVID-19 pandemic, patients with cancer are at increased risk of not having timely diagnosis and access to cancer treatment. The present study evaluated the COVID-19 pandemic impact on radiotherapy activity in Brazil.A national-level study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9278bba801823fb7db4381913c1bede0
https://pubmed.ncbi.nlm.nih.gov/36216270
https://pubmed.ncbi.nlm.nih.gov/36216270